ExodusPoint Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $67.1M | Buy |
777,986
+661,438
| +568% | +$55M | 0.35% | 39 |
|
|
2026
Q2 | $7.85M | Sell |
116,548
-200,519
| -63% | -$13.4M | 0.05% | 362 |
|
|
2026
Q1 | $19.9M | Buy |
317,067
+183,013
| +137% | +$12.7M | 0.16% | 104 |
|
|
2025
Q4 | $8.9M | Buy |
134,054
+98,240
| +274% | +$6.35M | 0.07% | 287 |
|
|
2025
Q3 | $2.41M | Sell |
35,814
-630,312
| -95% | -$49.9M | 0.02% | 675 |
|
|
2025
Q2 | $58.1M | Buy |
+666,126
| New | +$52.2M | 0.51% | 28 |
|
|
2025
Q1 | – | Sell |
-466,414
| Closed | -$36.3M | – | 1591 |
|
|
2024
Q4 | $36.3M | Buy |
466,414
+309,714
| +198% | +$22.9M | 0.25% | 60 |
|
|
2024
Q3 | $10.5M | Buy |
156,700
+104,667
| +201% | +$8.6M | 0.06% | 226 |
|
|
2024
Q2 | $5.9M | Sell |
52,033
-106,895
| -67% | -$13.5M | 0.04% | 360 |
|
|
2024
Q1 | $22M | Buy |
158,928
+150,277
| +1,737% | +$18.9M | 0.17% | 93 |
|
|
2023
Q4 | $1.07M | Sell |
8,651
-66,268
| -88% | -$6.77M | 0.01% | 797 |
|
|
2023
Q3 | $6.99M | Buy |
+74,919
| New | +$8.45M | 0.07% | 300 |
|
|
2023
Q2 | – | Sell |
-54,880
| Closed | -$6.38M | – | 1941 |
|
|
2023
Q1 | $6.38M | Sell |
54,880
-18,034
| -25% | -$2.02M | 0.05% | 428 |
|
|
2022
Q4 | $8.26M | Buy |
72,914
+67,747
| +1,311% | +$7.44M | 0.12% | 219 |
|
|
2022
Q3 | $416K | Sell |
5,167
-126,785
| -96% | -$10.7M | 0.01% | 1431 |
|
|
2022
Q2 | $9.8M | Buy |
131,952
+100,424
| +319% | +$9.17M | 0.12% | 197 |
|
|
2022
Q1 | $4.03M | Sell |
31,528
-20,408
| -39% | -$2.23M | 0.05% | 463 |
|
|
2021
Q4 | $6.97M | Buy |
51,936
+8,112
| +19% | +$1.17M | 0.07% | 323 |
|
|
2021
Q3 | $5.99M | Buy |
43,824
+28,068
| +178% | +$3.54M | 0.08% | 335 |
|
|
2021
Q2 | $1.68M | Buy |
+15,756
| New | +$1.51M | 0.02% | 763 |
|
|
2020
Q4 | – | Sell |
-1,460
| Closed | -$150K | – | 2049 |
|
|
2020
Q3 | $150K | Sell |
1,460
-31,132
| -96% | -$3.25M | ﹤0.01% | 1545 |
|
|
2020
Q2 | $3.3M | Sell |
32,592
-2,588
| -7% | -$232K | 0.09% | 261 |
|
|
2020
Q1 | $2.37M | Sell |
35,180
-9,856
| -22% | -$613K | 0.13% | 159 |
|
|
2019
Q4 | $2.46M | Sell |
45,036
-76,488
| -63% | -$3.63M | 0.05% | 292 |
|
|
2019
Q3 | $4.53M | Buy |
121,524
+110,040
| +958% | +$4.28M | 0.16% | 125 |
|
|
2019
Q2 | $430K | Sell |
11,484
-12,736
| -53% | -$400K | 0.02% | 534 |
|
|
2019
Q1 | $721K | Buy |
+24,220
| New | +$851K | 0.05% | 245 |
|
Other funds holding DXCM
ExodusPoint Capital Management's DXCM Position: Q3 2026 in Review
ExodusPoint Capital Management increased its DexCom (DXCM) stake by 568% in Q3 2026, buying an estimated $55M and bringing the position to 777,986 shares worth $67.1M. The position accounts for 0.35% of the portfolio, ranked #39.
ExodusPoint Capital Management first reported a position in DXCM in Q1 2019 and has held it in 27 quarters since. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- ExodusPoint Capital Management held 777,986 shares of DexCom worth $67.1M as of Q3 2026.
- ExodusPoint Capital Management bought 661,438 DexCom shares in Q3 2026, an estimated $55M.
- DexCom made up 0.35% of ExodusPoint Capital Management's portfolio in Q3 2026, its #39 holding.
- ExodusPoint Capital Management first reported a position in DexCom in Q1 2019 and has held it in 27 quarters since.
- 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.